Centers | ||
Chulalongkorn University Drug Discovery and Drug Development Research Center (Chula4DR) | VMCC, University of Michigan | Presude Life Sciences |
Chulalongkorn
Drug Discovery and Drug Development Research Center (Chula4DR) was
established in 2017, with the aim to facilitate advancement of academic
drug discovery and drug development research by leveraging innovations
and sciences... Read more |
The VMCC is an on-campus core facility for the design and synthesis of drug-like molecules and diagnostic probes used in biomedical investigations. Our Mission: To assist biomedical researchers in translating novel therapeutic hypotheses into... |
Presude Lifesciences is an integrated drug discovery and development services organization led by biopharma professionals with global experience. Read morePresude is a research driven company with expertise in medicinal chemistry, custom synthesis and... |
Partnerships |
Events |
Jobs |
Astra Zeneca and Broad Institute to Co-develop Antiviral and Antibacterial DrugsBroad Institute and Astrza Zeneca have entered into a two year collaboration agreement to co-develop antiviral and antibacterial drugs. Screening and target hit to lead chemistry will take place at Broad while Astra Zeneca will be responsible for... View all Pfizer's CTI Establishes New Partnership with UCSFPfizer's Center for Therapeutic Innovation has established a new multi-year research and development partnership with University of California, San Francisco (UCSF). Pfizer will provide $85 million in research and milestone payments over five year... View all Sanofi and Stanford's Bio-X to Collaborate on Early Stage ResearchSanofi and Stanford University's Bio-X have entered into a multi-year collaboration that support interdisciplinary collaborative research to be conducted at Stanford. A joint steering committee comprising of representatives from Stanford and... View all |
No EVENTS for listing |
No Job Posts |


